- Nordic Nanovector - Notice of Annual General Meeting on 28 June 2023
- Nordic Nanovector announces agreement to acquire Thor Medical, an emerging producer of alpha-emitters for radiopharmaceuticals to treat cancer
- Nordic Nanovector Publishes Data from the PARADIGME Phase 2 Clinical Trials with Betalutin® on European Clinical Trials Database
- NORDIC NANOVECTOR - ANNUAL GENERAL MEETING POSTPONED
- NORDIC NANOVECTOR - ANNUAL AND REMUNERATION REPORTS APPROVED
Nordic Nanovector ASA (8NN:DUS) closed at 0.0805, 70.55% above the 52 week low of 0.0472 set on May 26, 2023.
0.0472May 26 20230.7775Jun 10 2022
Short selling activityProvided by S&P Global Market Intelligence
|Market cap||111.28m NOK|
|EPS (TTM)||-2.70 |
Data delayed at least 15 minutes, as of Jun 07 2023 07:11 BST.